Showing results (851-860 of 5,007) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|March 26, 2015
MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancerAntonella Flacco, Vienna Ludovini, Fortunato Bianconi, et al.
American Journal of Clinical Oncology|February 1, 1985
Cisplatin, vinblastine, and bleomycin as second-trial therapy in ovarian carcinoma. A pilot study of the Gynecologic Oncology GroupF B Stehman, C E Ehrlich, S D Williams, et al.
American Journal of Clinical Oncology|February 1, 1985
Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinomaK S Sridhar, T Ohnuma, H Biller, et al.
American Journal of Clinical Oncology|July 24, 2020
Disparities in Surgical Recommendation for Stage I Non-Small Cell Lung CancerJoseph L Rapp, Stephanie Tuminello, Naomi Alpert, et al.
American Journal of Clinical Oncology|April 24, 2023
Feasibility Trial of Intensity Modulated Proton Therapy to Reduce Toxicity in Anal Cancer PatientsBailey Nelson, Teresa Meier, Yin Zhang, et al.
American Journal of Clinical Oncology|May 5, 2023
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk ModelXiangmei Sun, Yaru Peng, Jiaojiao Chen, et al.
American Journal of Clinical Oncology|January 7, 2014
Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution ExperienceMichelle M Kim, Bouthaina S Dabaja, Jeffrey Medeiros, et al.
American Journal of Clinical Oncology|January 7, 2014
Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of LifeShane Lloyd, Arie P Dosoretz, James B Yu, et al.
American Journal of Clinical Oncology|November 1, 2012
Outcome of female pediatric patients diagnosed with genital tract rhabdomyosarcoma based on analysis of cases registered in SEER database between 1973 and 2006Charles H Kirsch, Michael Goodman, Natia Esiashvili
American Journal of Clinical Oncology|November 1, 2012
A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study GroupYong Sang Hong, Sung Sook Lee, Kyu-pyo Kim, et al.
Pageof 501